Drugs / DC cell suspension
last change Aug 2018 re-read 2 minutes ago

DC cell suspension

Developed for
liver cancer
Investigated by
Ningbo Cancer Hospital

Trials 1 · a red edge is where a trial was stopped

2017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02873442 Aug 2016 → Mar 2018 liver cancer Ningbo Cancer Hospital Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DC cell suspension DC cell suspension (1×107 DC+ physiological saline” NCT02873442
Route Subcutaneous subcutaneous injection for each infusion” NCT02873442